chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Joint range of motion decreased, Muscle injury
Clinical narrative: feeling like a muscle injury; decline in range of motion; This is a spontaneous report from a contactable consumer or other non Health care professional (patient, self-reporting) via Pfizer Spontaneous Program. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration in arm on an unspecified date as single dose and second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported) via an unspecified route of administration in arm on an unspecified date as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced feeling like a muscle injury and decline in range of motion on an unspecified date. She reported that had her first and second dose of the COVID-19 vaccine, reporter stated that injections were both in the same arm, complaints of feeling like a muscle injury and decline in range of motion. The outcome of the events was unknown.  No follow up attempts are possible. Information about lot/ batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate decreased
Clinical narrative: her heart rate dropped to 40-45 beats per minute.; This is a spontaneous report from a contactable female consumer or other non hcp from a Pfizer-sponsored program. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch Number/Lot Number: Not reported) via an unspecified route of administration on an unspecified date as Dose 2, Single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch Number/Lot Number: Not reported) via an unspecified route of administration on an unspecified date as Dose 1, Single for COVID-19 immunization. The patient experienced her heart rate dropped to 40-45 beats per minute on an unspecified date. Patient had a weird side effect after the Covid vaccine with dose 2. The patient underwent lab tests and procedures which included heart rate: 40-45 on an unspecified date dropped to 40-45 beats per minute. The outcome of the event was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Heart rate, Nausea, Tachycardia
Clinical narrative: Dizziness; Tachycardia; Nausea; Diarrhoea; This is a spontaneous report from a contactable patient. A 36-year-old female received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: unknown) via an unspecified route of administration on an unspecified date in Jan2021 as single dose for COVID-19 immunization at hospital. Medical history was not reported. Patient had no known allergies. Concomitant medications were not reported. Patient did not receive any other vaccine in four weeks of Covid-19 vaccine. Patient did not have covid prior vaccination and was not tested for Covid post vaccination. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number EK5730) intramuscular in left deltoid on an unspecified date at 08:45am as single dose for COVID-19 immunization and experienced nausea and diarrhoea. On 11Jan2021 at 12:30 after second dose of vaccination, patient experienced dizziness and tachycardia [24th-48th hours after the vaccine]. On an unspecified date in 2021, after second dose patient experienced nausea and diarrhoea again. Patient underwent lab tests which included Heart rate monitored as 155 vesting (range 60-100). Adverse event did not result in a visit to Emergency room and Physician room. No culture was performed and there were no predisposing factors. Treatment received in response to the events was unknown. Outcome of the event was recovered on an unspecified date of Jan2021. Outcome of nausea and diarrhea was recovered on an unspecified date of 2021.  Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : PFIZER INC-2020508576 same patient, vaccine first dose events
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased
Clinical narrative: Fast heartbeat; This is a spontaneous report from a contactable consumer (Patient herself). A 72-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6265), via an unspecified route of administration, administered in Arm Left on 24Feb2021 12:45 (at the age of 72-years-old) as dose number unknown, single for covid-19 immunization at Pharmacy or Drug Store. The patient's medical history included hypertension. Concomitant medication included losartan and acetylsalicylic acid (ASPIRIN) (low dose aspirin) both for unknown indication and start stop date not reported. The patient had no other vaccine in four weeks. The patient had no covid prior vaccination. The patient was not tested for covid post vaccination. The patient previously took amoxicillin;clavulanic acid (AUGMENTINE) and alendronate and experienced known allergies. On 28Feb2021, the patient experienced fast heartbeat. The patient did not received treatment for event. The outcome of the event was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased, Weight
Clinical narrative: Rapid heart beat/my heart seemed to be beating faster when I woke up; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 75-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection,Batch/Lot Number: EL9Z6F) dose1, via an unspecified route of administration on 04Mar2021 (age at vaccination was 75 years) as single dose for covid-19 immunization. Medical history included diabetes mellitus from an unknown. Concomitant medication included insulin glargine (LANTUS) taken for an unspecified indication, start and stop date were not reported. On06Mar2021, the patient experienced rapid heartbeat/my heart seemed to be beating faster when woke up then it went back to normal. She wants to know if this is something she should be concerned about. Caller states she weights 220 lbs. The patient underwent lab tests and procedures which included heart rate: rapid on 06Mar2021 this morning heart seemed to be beating faster, weight: 54.43 kg on an unspecified date. the outcome of the events was recovered on 06Mar2021.  No follow-up attempts are possible. No further information is expected.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Heart rate, Heart rate increased
Clinical narrative: Rapid heartbeat and face flushed the next day; face flushed; This is a spontaneous report from a non-contactable consumer (patient). A 77-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration on 01Mar2021 at 15:00 as dose 1, single for covid-19 immunisation. Medical history included hypertension from an unspecified date. The patient had no known allergies. Concomitant medications included amoxicillin (AMOXICILLIN) taken for an unspecified indication, start and stop date were not reported; metronidazole (METRONIDAZOLE) taken for an unspecified indication, start and stop date were not reported received in two weeks of vaccination. The patient did not receive other vaccine in four weeks of vaccination. The patient was not diagnosed with COVID-19 prior vaccination. The patient has not been tested for COVID-19 post vaccination. On 02Mar2021 at 10:00, the patient experienced rapid heartbeat and face flushed the next day and face flushed. Adverse events resulted in Doctor or other healthcare professional office/clinic visit. Treatment for adverse events was Unknown. The patient underwent lab tests and procedures which included heartbeat (heart rate): Rapid heartbeat on 02Mar2021. The outcome of events was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased, Tachycardia
Clinical narrative: tachycardia; heartbeat was fast; This is a spontaneous report from a contactable consumer (patient). An 81-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection) via an unspecified route of administration on 03Mar2021 (Batch/Lot number: not reported) as first dose, single for COVID-19 immunization. Medical history included atrial fibrillation. The patient's concomitant medications were not reported. On 04Mar2021, the patient experienced an episode of tachycardia and heartbeat was fast. Patient wanted to know if this can be related to vaccine. She further asked that after the side effects she experienced, did she need to get the second dose. Laboratory tests on an unspecified date included heart rate: fast. The clinical outcome of the events was unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Crying, Depressed mood, Depression, Nausea
Clinical narrative: I started to cry; for 1 week I had depression; general sadness for 1 week; back aches; nausea; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 72-years-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL9266), via an unspecified route of administration on 22Feb2021 11:45 (at the age of 72-year-old) as dose 1, single for covid-19 immunisation.  Medical history included lung neoplasm malignant from an unknown date and unknown if ongoing Remission 9 years, known allergies- Highly sensitive to many drugs. No concomitant medications were taken. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other medications within 2 weeks of vaccination. On 22Feb2021, twenty minutes after vaccination, patient started to cry, for 1 week patient had depression, general sadness for 1 week, back aches, nausea. No treatment was taken as a result of events. The outcome of the events were recovered on an unspecified date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Tachycardia
Clinical narrative: Tachycardia 140's occurred for both vaccine; This is a spontaneous report from a contactable Other HCP (patient). A 41-years-old female patient received second dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EK9231; Expiration Date: 30Apr2021) via intramuscular in Deltoid Left on 20Jan2021 09:10 (age at vaccination was 41 Years old) as SINGLE for covid-19 immunization. On 20Jan2021 at 8:10 (one hour prior to 2nd vaccine), the patient administered with unspecified antipyretic (unknown dose). The patient medical history was unknown whereas, relevant tests was reported as none. The patient's concomitant medications were not reported. Patient previously received first dose bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EK5730 Expiration: 31Mar2021) via intramuscular in deltoid on 28Dec2020 11:00 (age at vaccination was 41 Years old) as SINGLE for covid-19 immunization and experienced GI issues, sore arm, chills, shivering, high fevers, tachycardia, head aches, nasal/sinus congestion, fatigue, dehydration, dizziness, sore throat. The patient experienced tachycardia 140's occurred for both vaccines on an unspecified date in 2021 and was resulted in physician office visit for the event. The outcome of the event tachycardia was unknown.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Gait disturbance, Headache, Heart rate, Heart rate increased
Clinical narrative: very fast heart rate; vice-like tightness across lower back; Weak /greater weakness; not walking straight forward; growing tightness of my lower back from side to side with significant pain; arm pain; severe headache; This is a spontaneous report from a contactable consumer (patient). An elderly non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EN9581) via an unspecified route of administration in Arm Right on 17Feb2021 08:30 as dose 1, single for COVID-19 immunisation at hospital. Medical history included known allergies. Concomitant medication taken in two weeks included montelukast sodium (SINGULAIR), hydrochlorothiazide (HYDROCHLOROTHIAZIDE), acetylsalicylic acid (ASPRIN), and VITAMINS all taken for an unspecified indication, start and stop date were not reported. Patient did not received other vaccine within four weeks of COVID vaccine. Patient did have COVID prior to vaccination. The patient experienced very fast heart rate, vice-like tightness across lower back, weak /greater weakness, not walking straight forward, arm pain, severe headache, growing tightness of my lower back from side to side with significant pain on 17Feb2021 08:45. Event reported as, within a half hour, very fast heart rate, vice-like tightness across lower back, weak and not walking straight forward. By evening, arm pain, severe headache, greater weakness, and growing tightness of my lower back from side to side with significant pain. All effects continued to increase for three and a half days until patient was taken to the emergency room. weeks later patient was a bit weak and have occasional minor pain. Treatment was received with many tests and then IV pain medication. Patient did not tested for COVID post vaccination. The patient underwent lab tests and procedures which included heart rate: very fast, laboratory test: unknown results on an unspecified date. Outcome of all the events were recovering.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test, Muscle tightness, Pain, Pain in extremity
Clinical narrative: very fast heart rate; vice-like tightness across lower back; Weak /greater weakness; not walking straight forward; growing tightness of my lower back from side to side with significant pain; arm pain; severe headache; This is a spontaneous report from a contactable consumer (patient). An elderly non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EN9581) via an unspecified route of administration in Arm Right on 17Feb2021 08:30 as dose 1, single for COVID-19 immunisation at hospital. Medical history included known allergies. Concomitant medication taken in two weeks included montelukast sodium (SINGULAIR), hydrochlorothiazide (HYDROCHLOROTHIAZIDE), acetylsalicylic acid (ASPRIN), and VITAMINS all taken for an unspecified indication, start and stop date were not reported. Patient did not received other vaccine within four weeks of COVID vaccine. Patient did have COVID prior to vaccination. The patient experienced very fast heart rate, vice-like tightness across lower back, weak /greater weakness, not walking straight forward, arm pain, severe headache, growing tightness of my lower back from side to side with significant pain on 17Feb2021 08:45. Event reported as, within a half hour, very fast heart rate, vice-like tightness across lower back, weak and not walking straight forward. By evening, arm pain, severe headache, greater weakness, and growing tightness of my lower back from side to side with significant pain. All effects continued to increase for three and a half days until patient was taken to the emergency room. weeks later patient was a bit weak and have occasional minor pain. Treatment was received with many tests and then IV pain medication. Patient did not tested for COVID post vaccination. The patient underwent lab tests and procedures which included heart rate: very fast, laboratory test: unknown results on an unspecified date. Outcome of all the events were recovering.  No follow-up attempts are possible. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Myalgia
Clinical narrative: Muscle pain in arm; Received vaccine while pregnant; This is a spontaneous report from a contactable consumer(Patient). A 41-years-old pregnant female patient received first dose of bnt162b2 (BNT162B2, PFIZER-BOTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6208), via an unspecified route of administration, administered in Arm Left on 16Mar2021 14:00 (Age at vaccination: 40-years-old) as single dose and second dose via an unspecified route of administration, administered in Arm Left on 06Apr2021 13:00 (Batch/Lot Number: ER8737) as single dose for covid-19 immunization. The patient medical history was not reported. Concomitant medication included ascorbic acid, betacarotene, calcium sulfate, colecalciferol, cyanocobalamin, ferrous fumarate, folic acid, nicotinamide, pyridoxine hydrochloride, retinol acetate, riboflavin, thiamine mononitrate, tocopheryl acetate, zinc oxide (PRENATAL VITAMINS) taken for an unspecified indication, start and stop date were not reported. last menstrual date was 25Sep2020. Gestational period was 25 weeks. expected  delivery date was 06Jul2021. Patient was not diagnosed with covid-19 prior to vaccination. Patient did not receive any other vaccine in four weeks. It was reported that on 16Mar2021 14:00 received vaccine while pregnant. Upon date 07Apr2021 it was reported that on 06Apr2021 received second dose while pregnant. Muscle pain in arm. Patient did not receive treatment for the events. Patient did not tested for covid post vaccination. The outcome for the event muscle pain in arm was reported as resolving at the time of this report.   Follow up information has been requested.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Extrasystoles, Fatigue, Tachycardia, Tremor
Clinical narrative: severe tachycardia; severe muscle tremor; fatigue; what seems to be a skip in my heart beat.; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 66-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: EN6198), via an unspecified route of administration, administered in arm left on 10Mar2021 09:30 AM (at the age of 66-year-old) as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient had no known allergies. Patient did not receive any other vaccine in four weeks. Patient did not receive any other medications in two weeks. Patient was not diagnosed with COVID prior vaccination. Patient was not COVID tested post vaccination. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: EN6200), via an unspecified route of administration, administered in arm left on 17Feb2021 09:30 AM (at the age of 66-year-old) as dose 1, single for COVID-19 immunization. On 11Mar2021, the patient experienced severe tachycardia, severe muscle tremor, fatigue, what seems to be a skip in my heartbeat. Adverse event: 16 hours post 2nd injection experienced severe tachycardia and severe muscle tremor on and off for several hours during the night. There is no history of this occurring. I am experiencing fatigue and what seems to be a skip in my heartbeat. The patient did not receive treatment for the events. Outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Heart rate, Heart rate increased
Clinical narrative: experienced fast heart beat; little lightheadedness; This is a spontaneous report from a contactable consumer (patient) reported for herself. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE Solution for injection Batch/Lot number was not reported) via an unspecified route of administration on 17Mar2021 11:30 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On 17Mar2021, the patient experienced fast heartbeat started around 12:50 after the vaccine and stated that she is feeling better now just a little lightheadedness on unspecified date in Mar2021 but other than that she is good and wanted to know what she should do. The patient underwent lab tests and procedures which included heartbeat resulted as experienced fast on 17Mar2021. The clinical outcome of the events was resolving.  No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Heart rate, Heart rate increased, Palpitations
Clinical narrative: fast heartbeat; Dizziness; Weakness; heart started palpitating; This is a spontaneous report from a contactable consumer (patient). A 63-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: ER2613, Expiration date: Unknown) via an unspecified route of administration, administered in left arm on 16Mar2021 13:30 (at the age of 63-years-old) as dose 1, single for COVID-19 immunization. History of all previous immunization with the Pfizer vaccine considered as suspect was none. No prior vaccinations were given within 4 weeks. Medical history included schizophrenia, blood cholesterol increased, gastrooesophageal reflux disease, calcium deficiency, breast cancer, bone loss, osteopenia, mastectomy. Family medical history was none. Concomitant medications included paliperidone (INVEGA [PALIPERIDONE]) taken for schizophrenia, from unknown start date to 05Mar201; atorvastatin taken for blood cholesterol increased from an unspecified start date and ongoing; famotidine taken for an unspecified indication from 05Mar2021 and ongoing; calcium taken for calcium deficiency from an unspecified start date and ongoing; anastrozole (ARIMIDEX) taken for bone loss, osteopenia, calcium deficiency, start and stop date were not reported. On 16Mar2021 at 15:30, the patient experienced fast heartbeat, dizziness, weakness and heart started palpitating. Patient stated right after the shot her heart started palpitating, fast heartbeat, happened all 16Mar2021 at 15:30 lasted till 5 am of 17Mar2021. Patient stated the fast heartbeat started the same time as heart palpitation, dizziness, and weakness and lasted all the way until about 5 am of 17Mar2021. The events did not result in emergency room or physician office. The patient stated the side effects are almost all gone. The patient underwent lab tests and procedures which included heart rate: fast on 16Mar2021. No treatment was given for the events. The outcome of the events was recovered on 17Mar2021.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Boredom, Fatigue, Heart rate, Heart rate irregular
Clinical narrative: fast heartbeat; Boredom; Fatigue; This is a spontaneous report from a contactable consumer (patient). A 83-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number and Expiration Date: unknown), via an unspecified route of administration on 07Mar2021 as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 07Mar2021, the patient experienced following symptoms fast heartbeat, boredom and fatigue. The patient underwent lab tests and procedures which included heart rate: fast on an unknown date. Outcome of events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Heart rate, Heart rate increased
Clinical narrative: fast heart rate/Pulse rate increased; headache; muscle aches; chills; joint pain; slight fever; ached all over; This is a spontaneous report from a contactable Nurse (Patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number and Expiration Date was not reported), via an unspecified route of administration on 18Mar2021 08:00 as DOE 2, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. The historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number and Expiration Date was not reported), via an unspecified route of administration on an unknown date as single dose for COVID-19 immunization. Patient stated that she received her 2nd dose on 18Mar2021, morning at 8 and didn't develop symptoms until after 5 pm. She had a fast heart rate, headache, muscle aches, chills, joint pain, and a slight fever. When she woke up twice during the night, she ached all over. She was in the 90s for her pulse rate and had a fever too. She drank something, went to bed and woke up again and was bounding. And today her pulse rate was 100-112. It did come down to the 80s. Patient also stated with Moderna's COVID vaccine, they're seeing up to weeks with a rapid pulse and was wondering if Pfizer's COVID vaccine was the same. The patient underwent lab tests and procedures which included heart rate: 90 on Mar2021 (I was in the 90s for my pulse rate), heart rate: 80 on Mar2021(It did come down to the 80s), heart rate: fast on Mar2021, heart rate: 100-112 on 18Mar2021 (today my pulse rate is 100-112). The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021307523 same reporter, different patient/drug/event
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Pyrexia
Clinical narrative: fast heart rate/Pulse rate increased; headache; muscle aches; chills; joint pain; slight fever; ached all over; This is a spontaneous report from a contactable Nurse (Patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number and Expiration Date was not reported), via an unspecified route of administration on 18Mar2021 08:00 as DOE 2, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. The historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number and Expiration Date was not reported), via an unspecified route of administration on an unknown date as single dose for COVID-19 immunization. Patient stated that she received her 2nd dose on 18Mar2021, morning at 8 and didn't develop symptoms until after 5 pm. She had a fast heart rate, headache, muscle aches, chills, joint pain, and a slight fever. When she woke up twice during the night, she ached all over. She was in the 90s for her pulse rate and had a fever too. She drank something, went to bed and woke up again and was bounding. And today her pulse rate was 100-112. It did come down to the 80s. Patient also stated with Moderna's COVID vaccine, they're seeing up to weeks with a rapid pulse and was wondering if Pfizer's COVID vaccine was the same. The patient underwent lab tests and procedures which included heart rate: 90 on Mar2021 (I was in the 90s for my pulse rate), heart rate: 80 on Mar2021(It did come down to the 80s), heart rate: fast on Mar2021, heart rate: 100-112 on 18Mar2021 (today my pulse rate is 100-112). The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021307523 same reporter, different patient/drug/event
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Disorientation, Dizziness, Loss of personal independence in daily activities, Pain, Respiratory rate increased
Clinical narrative: Fast breathing; lightheaded, dizzy; Disorientation.; Pains in upper and lower torso; Unable to work; This is a spontaneous report from a contactable consumer. This 72-year-old female consumer reported that:  A 72-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: EN6207 and Expiry date was not reported), dose 2 via an unspecified route of administration arm left on 19Mar2021 11:45 AM (age at vaccination was 72-year-old) as DOSE 2, single dose for covid-19 immunisation. Medical history included diabetes mellitus and known allergies like red fire ants, caterpillars from an unknown date and unknown if ongoing. The patient received other medications in two weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient received other vaccine in four weeks was BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: EN6198 and Expiry date was not reported), dose 1 via an unspecified route of administration in arm left on 26Feb2021 as DOSE 1, single dose for covid-19 immunisation. After administration of second dose, on 19Mar2021 12:15 PM patient experienced fast breathing, dizzy, lightheaded, disorientation, Pains in upper and lower torso and she was in 2day of pains, unable to work. No treatment received for the events. Outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dizziness, Headache, Heart rate
Clinical narrative: Chills; Muscle ache; Headache; achy all over; Fever; lightheaded; Fast heart rate; This is a spontaneous report from a contactable nurse (patient). A 66-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6204; Expiration Date: Jun2021), via an unspecified route of administration on 17Mar2021 (at the age of 66-year-old), as dose 2, single in left arm for COVID-19 immunization. The patient's medical history included heart racing; last fall was in 2020, after exertion, was checked out and everything came back normal. Concomitant medication included aspirin [acetylsalicylic acid] (ASPIRIN [ACETYLSALICYLIC ACID]), taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration on an unspecified date, as single dose for COVID-19 immunization. On 17Mar2021, after the second dose of vaccine, the patient experienced fast heart race, chills, muscle ache, headache, achy all over, fever and lightheaded. The patient underwent lab tests and procedures which included body temperature: 99-100 degrees on 17Mar2021, heart rate: fast, during night it was 90 on 17Mar2021 and heart rate: 112, morning it was still high, running around 112 on 18Mar2021. The clinical outcome of all the events was reported as not resolved.  No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Myalgia, Pain, Pyrexia
Clinical narrative: Chills; Muscle ache; Headache; achy all over; Fever; lightheaded; Fast heart rate; This is a spontaneous report from a contactable nurse (patient). A 66-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6204; Expiration Date: Jun2021), via an unspecified route of administration on 17Mar2021 (at the age of 66-year-old), as dose 2, single in left arm for COVID-19 immunization. The patient's medical history included heart racing; last fall was in 2020, after exertion, was checked out and everything came back normal. Concomitant medication included aspirin [acetylsalicylic acid] (ASPIRIN [ACETYLSALICYLIC ACID]), taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration on an unspecified date, as single dose for COVID-19 immunization. On 17Mar2021, after the second dose of vaccine, the patient experienced fast heart race, chills, muscle ache, headache, achy all over, fever and lightheaded. The patient underwent lab tests and procedures which included body temperature: 99-100 degrees on 17Mar2021, heart rate: fast, during night it was 90 on 17Mar2021 and heart rate: 112, morning it was still high, running around 112 on 18Mar2021. The clinical outcome of all the events was reported as not resolved.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Depressed mood
Clinical narrative: brought down to normal people level; This is a spontaneous report from a contactable consumer or other non hcp. This consumer reported for 4 patients. This report is for 4th of 4 patients. This consumer reported for a female patient (sister).  A female patient of an unspecified age received bnt162b2 (PFIZER-BIOTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as unknown single dose for covid-19 immunization. It was reported that While reporting on herself she was mentioned details about her sister when speaking about fatigue. She mentioned with the COVID 19 Vaccine with her and her sister it brought them down to normal people level on an unspecified date. Stated they were way up there anyways. The outcome for the even was reported as unknown at the time of this report.  No follow-up attempts are possible. Lot/Batch number cannot be requested. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Hyperhidrosis, Palpitations
Clinical narrative: severe heart palpitations; Break out in sweats; Freezing cold; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 67-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 Vaccine, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 11Mar2021 at 15:00 (3:00 PM) (at the age of 67-year-old) as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 12Mar2021 at 04:00 AM, the patient experienced severe heart palpitations, break out in sweats, freezing cold. 67-year-old female patient received Pfizer's COVID vaccine on 11Mar2021 at 3 pm. Patient stated, from 3 to midnight, I had no effects whatsoever, but from 12 am - 4 am, I was not well with heart palpitations. One minute I would break out in sweats and 5 minutes later I would be freezing cold. Since then, I've had no effects. My other shot is 01Apr2021. Patient is asking if it is safe for her to have the second dose. Patient also asking if there are any records of worse reactions after the second dose. The patient is calling about the covid vaccine. The patient had the first vaccine on 11Mar2021 and she had it at 3:00pm and was fine until midnight and then she started having severe heart palpitations, breaking out in sweats then to freezing and it lasted about 4 hours. This happened between midnight at 4:00 am. Since then she has been fine. The patient is scheduled for her second dose on 01Apr2021. Is it safe for her to get her second dose. Is this a reaction from the vaccine. Outcome of the events was recovered on an unspecified date in Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Wheezing
Clinical narrative: wheezing when breathed.; Gestation 26 weeks; This is a spontaneous report from a contactable consumer (patient). A 43-year-old pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot num-ber: EK(orR)8130 7/21), via an unspecified route of administration in the left arm on 23Mar2021 at 10:00 (at the age of 43-year-old) as a dose 1, single for COVID-19 immunisation. Maternal exposure during pregnancy second trimester (26 weeks). The medical history of the patient included renal tubular acidosis, hypertension, gestational diabetes. The patient was allergic to doxycycline, KEFLEX, OM-NICEF, amoxicillin, pollen, mold and animal danders. The patient last menstrual date was reported on 21Sep2020 and delivery date to be 26Jun2021. The concomitant medication of the patient included po-tassium chloride (KLOR-CON), cetirizine (ZYRTEC) and levothyroxine (MANUFACTURER UNKNOWN), labetalol (MANUFACTURER UNKNOWN) and insulin (MANUFACTURER UNKNOWN), all are taken on an unknown date. The patient experienced wheezing an hour and a half after the vaccine on 23Mar2021 at 11:30. Therapeutic measures were taken as a result of wheezing and included treatment with BEN-ADRYL and one puff of inhaler. The patient thinks symptoms were gone by about 20 minutes. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of wheezing was recovering at the time of this report.  Follow-up attempts completed. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Skin cancer
Clinical narrative: Mole surgery for possible skin cancer in the face.; This is a spontaneous report from a Pfizer sponsored program from a contactable  consumer (patient)   A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 02Mar2021 (Batch/Lot number was not reported) as 1ST DOSE, SINGLE for covid-19 immunisation  .  The patient medical history was not reported.     The patient's concomitant medications were not reported.  The patient stated that she will be having a procedure (mole surgery) tomorrow (on 19Mar2021) for possible skin cancer in the face. She wanted to know if that is okay or wait after taking her second dose. The first dose was given on 02Mar2021. She was scheduled to have her second dose on 23Mar2021.The outcome of the event was unknown  No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Red blood cell count, Red blood cell count decreased
Clinical narrative: red blood cells were low; This is a spontaneous report from a contactable other healthcare professional. This other HCP reported for a female patient (friend). A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunization. Caller stated her friend received the second dose of the vaccine and a couple days later her red blood cells were low. The patient underwent lab tests and procedures which included red blood cell count: low on unspecified date. The outcome of the event was unknown.   No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Flatulence, Maternal exposure during pregnancy
Clinical narrative: Gas trapped causung tightness in chest.; Gas trapped causung tightness in chest.; Maternal Exposure During Pregnancy, third trimester; This is a spontaneous report from a contactable consumer, the patient. This is a maternal report.  A 35-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EP7535), dose 1 via an unspecified route of administration, administered in Arm Left on 18Mar2021 13:30 as DOSE 1, SINGLE for covid-19 immunisation. Medical history included anxiety from an unknown date and unknown if ongoing, depression from an unknown date and unknown if ongoing. There were no concomitant medications. The patient previously took escitalopram (LEXAPRO) 25 mg, on unknown date for unspecified indication and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Mar2021 at 13:30, the patient was exposed to vaccine during pregnancy (gestation period of 33 weeks) and last menstrual date was reported as 26Jul2020. On 20Mar2021 at 12:00, the patient experienced trapped gas causing tightness in chest. Therapeutic measures were taken as a result of chest tightness and included treatment with two antacids. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of event chest tightness was recovering and of the maternal exposure during pregnancy was unknown at the time of pregnancy.  Follow-up (30Jun2021): Follow-up attempts completed. No further information expected.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Appetite disorder, Chills, Diarrhoea, Fatigue, Feeling abnormal
Clinical narrative: diarrhea; did not eat for a day other than little bit of Gatorade, patient lost 4.5 pounds; tired and fatigued; felt like 1000 monkeys with baseball bats was beating him; chills; Patient appetite is starting to pick up; This is a spontaneous report from a contactable consumer or other non health professional (patient). A 81-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: solution for injection, Lot Number: ER2613) via an unspecified route of administration, administered in arm right on 16Mar2021 at 12:00 (at the age of 81-years-old) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included reaction to penicillin (when he was a baby, he had a reaction to penicillin) and he had flu shots for immunization with no problems. There were no concomitant medications reported. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: solution for injection, Lot Number: EN6200) via an unspecified route of administration, administered in arm right on 23Feb2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient did not receive any other vaccines on the same day of vaccination. On 17Mar2021, the consumer stated that, a day and half afterwards he felt like 1000 monkeys with baseball bats were beating him. It started at the base of his neck, on his back to his shoulders and his elbows his back and hips and knees. He also had chills, diarrhea on 18Mar2021 and he didn't eat for a day other than a little bit of Gatorade. He lost about 4.5 pounds on 17Mar2021. He reported that he went to bed on the evening of 16Mar2021 and he was woken at around 1:20 AM, so about 13 hours after he received the vaccine. He tired and kind of fatigued today on 17Mar2021. He reported his appetite was starting to pick up on an unspecified date in 2021. He has had flu shots with no problems. Adverse events following prior vaccinations on the vaccine supplemental form, his mother told him when he was a baby, he had a reaction to penicillin. The adverse events did not require emergency room visit and physician office visit. The patient underwent lab tests and procedures which included weight lost: 4.5 lbs on 17Mar2021. The outcome of the events felt like 1000 monkeys with baseball bats was beating him, chills was recovered on 18Mar2021, diarrhea, tired and fatigued was not recovered, did not eat for a day other than little bit of Gatorade, patient lost 4.5 pounds, patient appetite is starting to pick up was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Weight, Weight decreased
Clinical narrative: diarrhea; did not eat for a day other than little bit of Gatorade, patient lost 4.5 pounds; tired and fatigued; felt like 1000 monkeys with baseball bats was beating him; chills; Patient appetite is starting to pick up; This is a spontaneous report from a contactable consumer or other non health professional (patient). A 81-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: solution for injection, Lot Number: ER2613) via an unspecified route of administration, administered in arm right on 16Mar2021 at 12:00 (at the age of 81-years-old) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included reaction to penicillin (when he was a baby, he had a reaction to penicillin) and he had flu shots for immunization with no problems. There were no concomitant medications reported. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: solution for injection, Lot Number: EN6200) via an unspecified route of administration, administered in arm right on 23Feb2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient did not receive any other vaccines on the same day of vaccination. On 17Mar2021, the consumer stated that, a day and half afterwards he felt like 1000 monkeys with baseball bats were beating him. It started at the base of his neck, on his back to his shoulders and his elbows his back and hips and knees. He also had chills, diarrhea on 18Mar2021 and he didn't eat for a day other than a little bit of Gatorade. He lost about 4.5 pounds on 17Mar2021. He reported that he went to bed on the evening of 16Mar2021 and he was woken at around 1:20 AM, so about 13 hours after he received the vaccine. He tired and kind of fatigued today on 17Mar2021. He reported his appetite was starting to pick up on an unspecified date in 2021. He has had flu shots with no problems. Adverse events following prior vaccinations on the vaccine supplemental form, his mother told him when he was a baby, he had a reaction to penicillin. The adverse events did not require emergency room visit and physician office visit. The patient underwent lab tests and procedures which included weight lost: 4.5 lbs on 17Mar2021. The outcome of the events felt like 1000 monkeys with baseball bats was beating him, chills was recovered on 18Mar2021, diarrhea, tired and fatigued was not recovered, did not eat for a day other than little bit of Gatorade, patient lost 4.5 pounds, patient appetite is starting to pick up was unknown.  No follow-up attempts are possible. No further information is expected.